Comprehending COVID-19: Rapid and Sensitive Characterization of N-Glycans from SARS-CoV-2 Spike Protein

Importance of the Topic

The SARS-CoV-2 spike protein mediates viral entry and is the primary target for neutralizing antibodies. Its dense array of N-glycans shapes protein folding, conformational dynamics, and immune recognition. Detailed mapping of these glycans supports rational vaccine design and therapeutic development by revealing structural motifs that modulate antigenicity and stability.

Objectives and Study Overview

This study aimed to establish a fast and sensitive workflow for the comprehensive profiling of N-linked glycans on the SARS-CoV-2 spike protein. By combining a rapid fluorescent labeling strategy with hydrophilic interaction chromatography and high-resolution mass spectrometry, the authors sought to identify and categorize the dominant glycoforms present.

Methodology

Recombinant spike protein was denatured under optimized reducing conditions and enzymatically treated to release N-glycans. Released glycans were labeled with a mass-and-fluorescence tag, purified, and separated by hydrophilic interaction liquid chromatography. Detection was performed using fluorescence measurement and accurate mass analysis, enabling assignment of glycan compositions based on retention times, glucose unit values, and mass data.

Used Instrumentation

• UPLC system: ACQUITY UPLC H-Class Bio
• Fluorescence detector: ACQUITY FLR
• Mass spectrometer: Xevo G2-XS QTof
• Chromatographic column: ACQUITY UPLC Glycan BEH Amide (1.7 μm, 2.1 × 150 mm) at 60 °C

Main Results and Discussion

The workflow resolved 42 major glycan peaks on the spike protein. Classification divided these into six high-mannose, six hybrid, and thirty complex glycans. Among complex forms, eleven were afucosylated, twenty-nine carried a single fucose, and two were tentatively assigned as doubly fucosylated species. These assignments were based on hydrophilic retention characteristics and accurate mass. The unexpected double fucosylation suggests unique glycoepitopes that warrant further confirmation via tandem MS and targeted exoglycosidase digestions.

Benefits and Practical Applications

• Enables rapid glycan profiling to accelerate antigen characterization in vaccine research.
• High sensitivity and simple sample preparation facilitate analysis of limited or precious materials.
• Fluorescent labeling enhances detection and quantitation of low-abundance glycoforms.

Future Trends and Application Opportunities

Advancing this approach by integrating targeted MS/MS sequencing and enzymatic mapping will refine structural annotations of spike glycans. High-throughput glycomics may uncover glycan-mediated immune evasion strategies and support variant monitoring. The methodology can also be applied to quality control in vaccine manufacturing and to studying glycosylation changes across emerging viral strains.

Conclusion

A streamlined fluorescent-labeling and LC-MS workflow enables sensitive and rapid profiling of SARS-CoV-2 spike N-glycans, revealing 42 dominant glycoforms and highlighting novel double-fucosylated species. Such detailed glycan maps are critical for understanding spike structure–function relationships and guiding vaccine and therapeutic development. Further structural validation will deepen insights into glycan roles in viral infectivity and immune recognition.

References

1. Novokmet M, et al. Understanding glycans in COVID-19 drug design. Genetic Engineering & Biotechnology News.
2. Pinto D, et al. Structural and functional analysis of a potent sarbecovirus neutralizing antibody. bioRxiv. 2020;2020.04.07.023903.
3. Stawiski EW, et al. Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility. bioRxiv. 2020;2020.04.07.024752.